Supplementary Data from Transcriptional Analysis of an E2F Gene Signature as a Biomarker of Activity of the Cyclin-Dependent Kinase Inhibitor PHA-793887 in Tumor and Skin Biopsies from a Phase I Clinical Study
posted on 2023-03-31, 23:26authored byGiuseppe Locatelli, Roberta Bosotti, Marina Ciomei, Maria G. Brasca, Raffaele Calogero, Ciro Mercurio, Francesco Fiorentini, Matteo Bertolotti, Emanuela Scacheri, Angela Scaburri, Arturo Galvani, Enrico Pesenti, Thierry De Baere, Jean-Charles Soria, Vladimir Lazar, Antonella Isacchi
Supplementary Data from Transcriptional Analysis of an E2F Gene Signature as a Biomarker of Activity of the Cyclin-Dependent Kinase Inhibitor PHA-793887 in Tumor and Skin Biopsies from a Phase I Clinical Study